- Home
- INTC vs NVS Comparison
INTC vs NVS Comparison
Compare INTC & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INTC | NVS |
|---|---|---|
| Founded | 1968 | 1895 |
| Country | United States | Switzerland |
| Employees | N/A | 75267 |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.7B | 278.6B |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | INTC | NVS |
|---|---|---|
| Price | $41.30 | $150.43 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 32 | 5 |
| Target Price | $43.60 | ★ $144.00 |
| AVG Volume (30 Days) | ★ 64.2M | 2.1M |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.08% |
| EPS Growth | ★ 98.63 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $52,853,000,000.00 | N/A |
| Revenue This Year | $3.96 | $2.56 |
| Revenue Next Year | $7.63 | $4.91 |
| P/E Ratio | ★ N/A | $23.13 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.67 | $97.72 |
| 52 Week High | $54.60 | $170.46 |
Technical Indicators
Market Signals| Indicator | INTC | NVS |
|---|---|---|
| Relative Strength Index (RSI) | 40.19 | 43.22 |
| Support Level | $34.18 | $145.30 |
| Resistance Level | $43.25 | $158.80 |
| Average True Range (ATR) | 2.24 | 2.14 |
| MACD | -0.32 | -0.66 |
| Stochastic Oscillator | 7.85 | 45.50 |
Price Performance
Historical ComparisonAbout INTC Intel Corporation
Intel is a leading digital chipmaker focused on designing and manufacturing microprocessors for the global personal computer and data center markets. Intel pioneered the x86 architecture for microprocessors and led the semiconductor industry down the path of Moore's law for advances in semiconductor manufacturing. Intel remains the market share leader in central processing units in both the PC and server end markets. The company is seeking to reinvigorate its chip manufacturing business, Intel Foundry, while developing leading-edge products in its Intel Products business segment.
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.